WENTWORTH KORY JAMES
SEC insider (Form 3/4/5 filer). CIK 0001725663. Chief Financial Officer at Entrada Therapeutics, Inc. (TRDA). 26 reported Form 4/5 transactions since Sep 2024; latest on Sep 2, 2026. Located in BOSTON, MA.
Companies WENTWORTH KORY JAMES has filed insider reports for
- Entrada Therapeutics, Inc. (TRDA): Officer, Chief Financial Officer
WENTWORTH KORY JAMES
CIK: 0001725663
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Entrada Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (26 total)
- Sep 2, 2026TRDA
Entrada Therapeutics, Inc.
Tax PaymentDirect1.7K shares at avg. $7.14$12K - Apr 1, 2026TRDA
Entrada Therapeutics, Inc.
SaleDirect2.5K shares at avg. $12.95$32K - Mar 10, 2026TRDA
Entrada Therapeutics, Inc.
SaleDirect11.4K shares at avg. $13.02$148K - Mar 9, 2026TRDA
Entrada Therapeutics, Inc.
SaleDirect5.1K shares at avg. $13.00$66K - Mar 4, 2026TRDA
Entrada Therapeutics, Inc.
SaleDirect8K shares at avg. $12.25$98K - Mar 3, 2026TRDA
Entrada Therapeutics, Inc.
Tax PaymentDirect5.7K shares at avg. $11.76$67K - Mar 2, 2026TRDA
Entrada Therapeutics, Inc.
Tax PaymentDirect2.9K shares at avg. $11.66$34K - Mar 1, 2026TRDA
Entrada Therapeutics, Inc.
AwardDirect44.6K shares- - Nov 21, 2025TRDA
Entrada Therapeutics, Inc.
SaleDirect8.9K shares at avg. $9.98$89K - Sep 2, 2025TRDA
Entrada Therapeutics, Inc.
Tax PaymentDirect1.7K shares at avg. $5.43$9K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 2, 2026 | TRDA Entrada Therapeutics, Inc. | Tax Payment | 1,733 | $7.14 | $12,380 | Direct |
| Apr 1, 2026 | TRDA Entrada Therapeutics, Inc. | Sale | 2,500 | $12.95 | $32,375 | Direct |
| Mar 10, 2026 | TRDA Entrada Therapeutics, Inc. | Sale | 11,388 | $13.02 | $148,216 | Direct |
| Mar 9, 2026 | TRDA Entrada Therapeutics, Inc. | Sale | 5,089 | $13.00 | $66,163 | Direct |
| Mar 4, 2026 | TRDA Entrada Therapeutics, Inc. | Sale | 7,988 | $12.25 | $97,892 | Direct |
| Mar 3, 2026 | TRDA Entrada Therapeutics, Inc. | Tax Payment | 5,712 | $11.76 | $67,153 | Direct |
| Mar 2, 2026 | TRDA Entrada Therapeutics, Inc. | Tax Payment | 2,939 | $11.66 | $34,263 | Direct |
| Mar 1, 2026 | TRDA Entrada Therapeutics, Inc. | Award | 44,600 | - | $0 | Direct |
| Nov 21, 2025 | TRDA Entrada Therapeutics, Inc. | Sale | 8,910 | $9.98 | $88,932 | Direct |
| Sep 2, 2025 | TRDA Entrada Therapeutics, Inc. | Tax Payment | 1,734 | $5.43 | $9,416 | Direct |
1-10 of 26 transactions